BioCentury
ARTICLE | Company News

SunPharm, Schein Pharmaceutical Inc. deal

October 11, 1999 7:00 AM UTC

Schein received an exclusive license in the U.S., Europe and certain Far East territories to a SUNP iron chelation compound to treat iron overload conditions. SUNP is eligible for milestone payments a...